Oncology & Cancer

CheckMate 743 shows that dual immunotherapy, nivolumab + ipilimumab

The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for patients with unresectable malignant pleural mesothelioma compared to platinum-based chemotherapy, according to research ...

Medications

Immunotherapy for bowel cancer could change clinical practice

A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of ...

Oncology & Cancer

New lung cancer trial to help predict relapse

A new international Phase 3 clinical trial coordinated by Crick Senior Group Leader and Cancer Research UK's chief clinician, Charles Swanton, will use personalised detection tests to look for the earliest signs of relapse ...

page 14 from 40